CTI BioPharma
CTIC
#5622
Rank
A$1.80 B
Marketcap
A$13.68
Share price
0.00%
Change (1 day)
27.00%
Change (1 year)

Revenue for CTI BioPharma (CTIC)

Revenue in 2023 (TTM): A$0.11 Billion

According to CTI BioPharma 's latest financial reports the company's current revenue (TTM ) is A$0.11 Billion. In 2022 the company made a revenue of A$79.27 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CTI BioPharma from 1997 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) A$0.11 B42.82%
2022 A$79.27 M
2021 N/A
2020 N/A-100%
2019 A$4.77 M-87.02%
2018 A$36.79 M14.24%
2017 A$32.2 M-59.56%
2016 A$79.63 M259.99%
2015 A$22.12 M-69.86%
2014 A$73.4 M88.82%
2013 A$38.87 M
2012 N/A
2011 N/A-100%
2010 A$0.31 M252.64%
2009 A$0.08 M-99.45%
2008 A$16.2 M11054.78%
2007 A$0.14 M43.14%
2006 A$0.1 M-99.54%
2005 A$21.99 M-42.49%
2004 A$38.24 M14.78%
2003 A$33.31 M11.1%
2002 A$29.98 M145.43%
2001 A$12.21 M1260.8%
2000 A$0.89 M96.68%
1999 A$0.45 M-97.88%
1998 A$21.55 M19.03%
1997 A$18.11 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
A$54.15 B 47,374.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$72.31 B 63,295.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$7.24 B 6,252.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$16.59 B 14,448.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$89.45 B 78,322.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.25 B 22,040.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$84.86 B 74,299.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland